VITSX | VTCLX | VITSX / VTCLX | |
Total Expense Ratio | 0.03 | 0.09 | 33% |
Annual Report Gross Expense Ratio | 0.03 | 0.09 | 33% |
Fund Existence | 28 years | 31 years | - |
Gain YTD | 8.083 | 8.502 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 10000 | 50,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.91T | 25.2B | 7,587% |
Annual Yield % from dividends | 1.19 | 0.98 | 122% |
Returns for 1 year | 19.69 | 20.40 | 96% |
Returns for 3 years | 51.97 | 54.48 | 95% |
Returns for 5 years | 84.99 | 89.34 | 95% |
Returns for 10 years | 201.91 | 206.50 | 98% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FMED | 23.16 | 0.18 | +0.80% |
Fidelity Disruptive Medicine ETF | |||
FYX | 99.70 | 0.28 | +0.28% |
First Trust Small Cap Core AlphaDEX® ETF | |||
CZAR | 31.44 | N/A | N/A |
Themes Natural Monopoly ETF | |||
VCSH | 79.38 | -0.08 | -0.10% |
Vanguard Short-Term Corporate Bond ETF | |||
WIA | 8.35 | -0.02 | -0.29% |
Western Asset Inflation-Linked Income Fund |